Given the multiple targets of THZ1, we asked whether selective inhibition of CDK7 would be sufficient to induce cytotoxicity in NB and whether its therapeutic effects could be attributed to inhibition of CDK7-mediated transcription, cell cycle progression or both. This evidence concerns the gene CDK7 and neuroblastoma.